Inhibitory activity of caffeoylquinic acids from the aerial parts of Artemisia princes on rat lens aldose reductase and on the formation of advanced glycation end products

被引:0
作者
Cheng-Bi Cui
Seung Kyoung Jeong
Yeon Sil Lee
Soon Ok Lee
Il-Jun Kang
Soon Sung Lim
机构
[1] Yanbian University,Department of Agriculture
[2] Hallym University,Medical & Bio
[3] Hallym University,material Research Center and Department of Food Science and Nutrition
[4] Korea Tourism College,Center for Efficacy Assessment and Development of Functional Foods and Drugs
来源
Journal of the Korean Society for Applied Biological Chemistry | 2009年 / 52卷
关键词
advanced glycation end products; caffeoylquinic acids; rat lens aldose reductase;
D O I
暂无
中图分类号
学科分类号
摘要
Caffeoylquinic acids -3,4-di-O-caffeoylquinic acid (1); 1,3,5-tri-O-caffeoylquinic acid (2); and 3,4,5-tri-O-caffeoylqunic acid (3)- were isolated from an acetone-soluble fraction of the aerial parts of Artemisia princes. Their structures were determined spectroscopically using 1D- and 2D-nuclear magnetic resonance (NMR) studies, as well as by comparing the NMR results with previously published structures. All the isolates were subjected to in vitro bioassays to evaluate their efficacy in inhibiting rat lens aldose reductase (RLAR) activity and the formation of advanced glycation end products (AGEs). We found 1,3,5-tri-O-caffeoylquinic acid (2) to be the most potent AGE inhibitor, and the concentration that resulted in 50% inhibition (IC50) was 22.18 ±1.46 mM, as compared to the aminoguanidine and chlorogenic acid controls, which had IC50 values of 1,093.11±10.95 and 117.63±0.20 mM, respectively. In the RLAR assay, the three caffeoylquinic acids were found to have IC50 values in the range of 1.78-2.40 μM, demonstrating a 5- to 10-fold greater efficacy in RLAR inhibition as compared to the quercetin control, which had an IC50 value of 17.91 μM.
引用
收藏
页码:655 / 662
页数:7
相关论文
共 211 条
[1]  
Agata I(1993)1,3,5-Tri-O-caffeoylquinic acid from Phytochemistry 33 508-509
[2]  
Goto S(2005)Advanced glycation endproducts-role in pathology of diabetic complications Diabetes Res Clin Pract 67 3-21
[3]  
Hatano T(2009)Aldose reductase enzyme and its implication to major health problems of the 21(st) century Curr Med Chem 16 734-752
[4]  
Nishibe S(1986)Treatment of diabetes mellitus by Artemisia herba-alba extract: Preliminary study Clin Exp Pharmacol Physiol 13 569-673
[5]  
Okuda T(1996)Four di- Biol Pharm Bull 19 1479-1484
[6]  
Ahmed N(2008)-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models Chem Pharm Bull 56 1168-1162
[7]  
Alexiou P(2001)A cytotoxic and apoptosis-inducing sesquiterpenoid isolated from the aerial parts of Nature 414 813-820
[8]  
Pegklidou K(2009) PAMPANINI (Sajabalssuk) J Pharm Pharmacol 61 1043-1050
[9]  
Chatzopoulou M(2005)Biochemistry and molecular cell biology of diabetic complications Curr Drug Targets 6 475-486
[10]  
Nicolaou I(1997)Anti-inflammatory effects of Artemisia princeps in antigen-stimulated T cell and regulatory T cells Diabetes Rev 5 177-269